nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—Carboplatin—uterine cancer	0.232	0.345	CbGbCtD
Clomipramine—GSTP1—Etoposide—uterine cancer	0.195	0.29	CbGbCtD
Clomipramine—CYP2C19—Progesterone—uterine cancer	0.0353	0.0525	CbGbCtD
Clomipramine—CYP1A2—Progesterone—uterine cancer	0.0326	0.0484	CbGbCtD
Clomipramine—ABCB1—Progesterone—uterine cancer	0.0285	0.0423	CbGbCtD
Clomipramine—CYP2D6—Progesterone—uterine cancer	0.0268	0.0399	CbGbCtD
Clomipramine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0257	0.0383	CbGbCtD
Clomipramine—ABCB1—Dactinomycin—uterine cancer	0.0226	0.0336	CbGbCtD
Clomipramine—CYP3A4—Progesterone—uterine cancer	0.0171	0.0254	CbGbCtD
Clomipramine—CYP1A2—Etoposide—uterine cancer	0.0146	0.0217	CbGbCtD
Clomipramine—ABCB1—Etoposide—uterine cancer	0.0127	0.0189	CbGbCtD
Clomipramine—ABCB1—Doxorubicin—uterine cancer	0.00869	0.0129	CbGbCtD
Clomipramine—CYP2D6—Doxorubicin—uterine cancer	0.00819	0.0122	CbGbCtD
Clomipramine—CYP3A4—Etoposide—uterine cancer	0.00763	0.0114	CbGbCtD
Clomipramine—CYP3A4—Doxorubicin—uterine cancer	0.00521	0.00774	CbGbCtD
Clomipramine—GSTP1—oviduct—uterine cancer	0.00485	0.098	CbGeAlD
Clomipramine—GSTP1—exocrine gland—uterine cancer	0.0028	0.0566	CbGeAlD
Clomipramine—GSTP1—myometrium—uterine cancer	0.00155	0.0314	CbGeAlD
Clomipramine—HTR2A—artery—uterine cancer	0.00141	0.0286	CbGeAlD
Clomipramine—HTR2B—myometrium—uterine cancer	0.00128	0.0259	CbGeAlD
Clomipramine—GSTP1—epithelium—uterine cancer	0.00122	0.0246	CbGeAlD
Clomipramine—GSTP1—uterine cervix—uterine cancer	0.00121	0.0244	CbGeAlD
Clomipramine—GSTP1—smooth muscle tissue—uterine cancer	0.00117	0.0237	CbGeAlD
Clomipramine—GSTP1—decidua—uterine cancer	0.00115	0.0233	CbGeAlD
Clomipramine—GSTP1—renal system—uterine cancer	0.00113	0.0228	CbGeAlD
Clomipramine—GSTP1—endometrium—uterine cancer	0.00109	0.0221	CbGeAlD
Clomipramine—GSTP1—mammalian vulva—uterine cancer	0.00106	0.0214	CbGeAlD
Clomipramine—GSTP1—uterus—uterine cancer	0.00101	0.0203	CbGeAlD
Clomipramine—HTR2B—uterine cervix—uterine cancer	0.000996	0.0201	CbGeAlD
Clomipramine—HTR2B—smooth muscle tissue—uterine cancer	0.000968	0.0196	CbGeAlD
Clomipramine—HTR2B—decidua—uterine cancer	0.000949	0.0192	CbGeAlD
Clomipramine—GSTP1—female reproductive system—uterine cancer	0.000905	0.0183	CbGeAlD
Clomipramine—HTR2B—endometrium—uterine cancer	0.000901	0.0182	CbGeAlD
Clomipramine—SLC6A2—decidua—uterine cancer	0.000843	0.017	CbGeAlD
Clomipramine—HTR2B—uterus—uterine cancer	0.00083	0.0168	CbGeAlD
Clomipramine—GSTP1—female gonad—uterine cancer	0.000824	0.0166	CbGeAlD
Clomipramine—GSTP1—vagina—uterine cancer	0.000819	0.0165	CbGeAlD
Clomipramine—ADRA2A—myometrium—uterine cancer	0.000804	0.0162	CbGeAlD
Clomipramine—HTR2C—female reproductive system—uterine cancer	0.000795	0.0161	CbGeAlD
Clomipramine—SLC6A4—female reproductive system—uterine cancer	0.000753	0.0152	CbGeAlD
Clomipramine—HTR2B—female reproductive system—uterine cancer	0.000746	0.0151	CbGeAlD
Clomipramine—HRH2—lymph node—uterine cancer	0.000735	0.0149	CbGeAlD
Clomipramine—HTR2B—vagina—uterine cancer	0.000675	0.0136	CbGeAlD
Clomipramine—SLC6A2—female reproductive system—uterine cancer	0.000663	0.0134	CbGeAlD
Clomipramine—CYP1A2—renal system—uterine cancer	0.000637	0.0129	CbGeAlD
Clomipramine—ADRA2A—uterine cervix—uterine cancer	0.000626	0.0126	CbGeAlD
Clomipramine—ADRA2A—decidua—uterine cancer	0.000596	0.012	CbGeAlD
Clomipramine—ADRA2A—endometrium—uterine cancer	0.000566	0.0114	CbGeAlD
Clomipramine—CYP2C19—vagina—uterine cancer	0.000564	0.0114	CbGeAlD
Clomipramine—ADRA2A—mammalian vulva—uterine cancer	0.000547	0.0111	CbGeAlD
Clomipramine—HTR2A—epithelium—uterine cancer	0.000537	0.0108	CbGeAlD
Clomipramine—GSTP1—lymph node—uterine cancer	0.000529	0.0107	CbGeAlD
Clomipramine—ADRA2A—uterus—uterine cancer	0.000521	0.0105	CbGeAlD
Clomipramine—HTR2A—smooth muscle tissue—uterine cancer	0.000517	0.0104	CbGeAlD
Clomipramine—HTR2A—renal system—uterine cancer	0.000498	0.0101	CbGeAlD
Clomipramine—ADRA2A—female reproductive system—uterine cancer	0.000469	0.00947	CbGeAlD
Clomipramine—CYP3A4—renal system—uterine cancer	0.000461	0.00931	CbGeAlD
Clomipramine—ALB—lymph node—uterine cancer	0.000453	0.00916	CbGeAlD
Clomipramine—CYP2D6—renal system—uterine cancer	0.000453	0.00916	CbGeAlD
Clomipramine—ABCB1—myometrium—uterine cancer	0.000448	0.00905	CbGeAlD
Clomipramine—HTR2B—lymph node—uterine cancer	0.000437	0.00882	CbGeAlD
Clomipramine—ADRA2A—female gonad—uterine cancer	0.000427	0.00862	CbGeAlD
Clomipramine—ADRA2A—vagina—uterine cancer	0.000424	0.00856	CbGeAlD
Clomipramine—HTR2A—female reproductive system—uterine cancer	0.000399	0.00805	CbGeAlD
Clomipramine—SLC6A2—lymph node—uterine cancer	0.000388	0.00784	CbGeAlD
Clomipramine—CYP3A4—female reproductive system—uterine cancer	0.000369	0.00745	CbGeAlD
Clomipramine—CYP2D6—female reproductive system—uterine cancer	0.000363	0.00734	CbGeAlD
Clomipramine—HTR2A—vagina—uterine cancer	0.00036	0.00728	CbGeAlD
Clomipramine—ABCB1—epithelium—uterine cancer	0.000352	0.0071	CbGeAlD
Clomipramine—ABCB1—uterine cervix—uterine cancer	0.000349	0.00704	CbGeAlD
Clomipramine—ABCB1—decidua—uterine cancer	0.000332	0.00671	CbGeAlD
Clomipramine—CYP2D6—female gonad—uterine cancer	0.00033	0.00667	CbGeAlD
Clomipramine—ABCB1—renal system—uterine cancer	0.000326	0.00659	CbGeAlD
Clomipramine—ABCB1—endometrium—uterine cancer	0.000315	0.00637	CbGeAlD
Clomipramine—ABCB1—mammalian vulva—uterine cancer	0.000305	0.00616	CbGeAlD
Clomipramine—ABCB1—uterus—uterine cancer	0.000291	0.00587	CbGeAlD
Clomipramine—ADRA2A—lymph node—uterine cancer	0.000274	0.00554	CbGeAlD
Clomipramine—ABCB1—female reproductive system—uterine cancer	0.000261	0.00528	CbGeAlD
Clomipramine—ABCB1—female gonad—uterine cancer	0.000238	0.0048	CbGeAlD
Clomipramine—ABCB1—vagina—uterine cancer	0.000236	0.00477	CbGeAlD
Clomipramine—ABCB1—lymph node—uterine cancer	0.000153	0.00309	CbGeAlD
Clomipramine—Thrombocytopenia—Etoposide—uterine cancer	0.000116	0.000436	CcSEcCtD
Clomipramine—Tachycardia—Etoposide—uterine cancer	0.000115	0.000435	CcSEcCtD
Clomipramine—Eosinophilia—Epirubicin—uterine cancer	0.000115	0.000435	CcSEcCtD
Clomipramine—Skin disorder—Etoposide—uterine cancer	0.000115	0.000432	CcSEcCtD
Clomipramine—Dry skin—Doxorubicin—uterine cancer	0.000114	0.000431	CcSEcCtD
Clomipramine—Hyperhidrosis—Etoposide—uterine cancer	0.000114	0.00043	CcSEcCtD
Clomipramine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000114	0.000429	CcSEcCtD
Clomipramine—Hypokalaemia—Doxorubicin—uterine cancer	0.000114	0.000428	CcSEcCtD
Clomipramine—Breast disorder—Doxorubicin—uterine cancer	0.000113	0.000425	CcSEcCtD
Clomipramine—Anorexia—Etoposide—uterine cancer	0.000113	0.000424	CcSEcCtD
Clomipramine—Bronchitis—Epirubicin—uterine cancer	0.000112	0.000422	CcSEcCtD
Clomipramine—Diarrhoea—Dactinomycin—uterine cancer	0.000112	0.000421	CcSEcCtD
Clomipramine—Pancytopenia—Epirubicin—uterine cancer	0.000111	0.000417	CcSEcCtD
Clomipramine—Hypotension—Etoposide—uterine cancer	0.000111	0.000416	CcSEcCtD
Clomipramine—Gastritis—Doxorubicin—uterine cancer	0.00011	0.000416	CcSEcCtD
Clomipramine—Muscular weakness—Doxorubicin—uterine cancer	0.00011	0.000414	CcSEcCtD
Clomipramine—Dysuria—Epirubicin—uterine cancer	0.000109	0.00041	CcSEcCtD
Clomipramine—Dysphagia—Doxorubicin—uterine cancer	0.000108	0.000406	CcSEcCtD
Clomipramine—Pollakiuria—Epirubicin—uterine cancer	0.000108	0.000405	CcSEcCtD
Clomipramine—Eosinophilia—Doxorubicin—uterine cancer	0.000107	0.000402	CcSEcCtD
Clomipramine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000106	0.000401	CcSEcCtD
Clomipramine—Paraesthesia—Etoposide—uterine cancer	0.000106	0.0004	CcSEcCtD
Clomipramine—Weight increased—Epirubicin—uterine cancer	0.000106	0.000399	CcSEcCtD
Clomipramine—Weight decreased—Epirubicin—uterine cancer	0.000106	0.000397	CcSEcCtD
Clomipramine—Dyspnoea—Etoposide—uterine cancer	0.000105	0.000397	CcSEcCtD
Clomipramine—Hyperglycaemia—Epirubicin—uterine cancer	0.000105	0.000396	CcSEcCtD
Clomipramine—Somnolence—Etoposide—uterine cancer	0.000105	0.000396	CcSEcCtD
Clomipramine—Pneumonia—Epirubicin—uterine cancer	0.000105	0.000394	CcSEcCtD
Clomipramine—Drowsiness—Epirubicin—uterine cancer	0.000104	0.000391	CcSEcCtD
Clomipramine—Vomiting—Dactinomycin—uterine cancer	0.000104	0.000391	CcSEcCtD
Clomipramine—Bronchitis—Doxorubicin—uterine cancer	0.000104	0.000391	CcSEcCtD
Clomipramine—Rash—Dactinomycin—uterine cancer	0.000103	0.000388	CcSEcCtD
Clomipramine—Decreased appetite—Etoposide—uterine cancer	0.000103	0.000387	CcSEcCtD
Clomipramine—Pancytopenia—Doxorubicin—uterine cancer	0.000102	0.000386	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000102	0.000384	CcSEcCtD
Clomipramine—Fatigue—Etoposide—uterine cancer	0.000102	0.000384	CcSEcCtD
Clomipramine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000102	0.000384	CcSEcCtD
Clomipramine—Jaundice—Epirubicin—uterine cancer	0.000101	0.000381	CcSEcCtD
Clomipramine—Pain—Etoposide—uterine cancer	0.000101	0.000381	CcSEcCtD
Clomipramine—Constipation—Etoposide—uterine cancer	0.000101	0.000381	CcSEcCtD
Clomipramine—Conjunctivitis—Epirubicin—uterine cancer	0.000101	0.00038	CcSEcCtD
Clomipramine—Urinary tract infection—Epirubicin—uterine cancer	0.000101	0.00038	CcSEcCtD
Clomipramine—Dysuria—Doxorubicin—uterine cancer	0.000101	0.00038	CcSEcCtD
Clomipramine—Sweating—Epirubicin—uterine cancer	9.97e-05	0.000375	CcSEcCtD
Clomipramine—Pollakiuria—Doxorubicin—uterine cancer	9.97e-05	0.000375	CcSEcCtD
Clomipramine—Haematuria—Epirubicin—uterine cancer	9.91e-05	0.000373	CcSEcCtD
Clomipramine—Photosensitivity reaction—Doxorubicin—uterine cancer	9.85e-05	0.000371	CcSEcCtD
Clomipramine—Hepatobiliary disease—Epirubicin—uterine cancer	9.83e-05	0.00037	CcSEcCtD
Clomipramine—Weight increased—Doxorubicin—uterine cancer	9.82e-05	0.00037	CcSEcCtD
Clomipramine—Epistaxis—Epirubicin—uterine cancer	9.81e-05	0.000369	CcSEcCtD
Clomipramine—Weight decreased—Doxorubicin—uterine cancer	9.76e-05	0.000367	CcSEcCtD
Clomipramine—Sinusitis—Epirubicin—uterine cancer	9.76e-05	0.000367	CcSEcCtD
Clomipramine—Feeling abnormal—Etoposide—uterine cancer	9.75e-05	0.000367	CcSEcCtD
Clomipramine—Hyperglycaemia—Doxorubicin—uterine cancer	9.73e-05	0.000366	CcSEcCtD
Clomipramine—Nausea—Dactinomycin—uterine cancer	9.71e-05	0.000365	CcSEcCtD
Clomipramine—Agranulocytosis—Epirubicin—uterine cancer	9.7e-05	0.000365	CcSEcCtD
Clomipramine—Pneumonia—Doxorubicin—uterine cancer	9.68e-05	0.000364	CcSEcCtD
Clomipramine—Gastrointestinal pain—Etoposide—uterine cancer	9.67e-05	0.000364	CcSEcCtD
Clomipramine—Drowsiness—Doxorubicin—uterine cancer	9.62e-05	0.000362	CcSEcCtD
Clomipramine—Bradycardia—Epirubicin—uterine cancer	9.5e-05	0.000358	CcSEcCtD
Clomipramine—Neuropathy peripheral—Doxorubicin—uterine cancer	9.43e-05	0.000355	CcSEcCtD
Clomipramine—Urticaria—Etoposide—uterine cancer	9.4e-05	0.000354	CcSEcCtD
Clomipramine—Jaundice—Doxorubicin—uterine cancer	9.38e-05	0.000353	CcSEcCtD
Clomipramine—Rhinitis—Epirubicin—uterine cancer	9.36e-05	0.000352	CcSEcCtD
Clomipramine—Abdominal pain—Etoposide—uterine cancer	9.35e-05	0.000352	CcSEcCtD
Clomipramine—Body temperature increased—Etoposide—uterine cancer	9.35e-05	0.000352	CcSEcCtD
Clomipramine—Conjunctivitis—Doxorubicin—uterine cancer	9.35e-05	0.000352	CcSEcCtD
Clomipramine—Urinary tract infection—Doxorubicin—uterine cancer	9.35e-05	0.000352	CcSEcCtD
Clomipramine—Hepatitis—Epirubicin—uterine cancer	9.33e-05	0.000351	CcSEcCtD
Clomipramine—Hypoaesthesia—Epirubicin—uterine cancer	9.29e-05	0.00035	CcSEcCtD
Clomipramine—Pharyngitis—Epirubicin—uterine cancer	9.26e-05	0.000349	CcSEcCtD
Clomipramine—Sweating—Doxorubicin—uterine cancer	9.22e-05	0.000347	CcSEcCtD
Clomipramine—Urinary tract disorder—Epirubicin—uterine cancer	9.22e-05	0.000347	CcSEcCtD
Clomipramine—Haematuria—Doxorubicin—uterine cancer	9.17e-05	0.000345	CcSEcCtD
Clomipramine—Connective tissue disorder—Epirubicin—uterine cancer	9.17e-05	0.000345	CcSEcCtD
Clomipramine—Urethral disorder—Epirubicin—uterine cancer	9.15e-05	0.000344	CcSEcCtD
Clomipramine—Hepatobiliary disease—Doxorubicin—uterine cancer	9.1e-05	0.000342	CcSEcCtD
Clomipramine—Epistaxis—Doxorubicin—uterine cancer	9.08e-05	0.000342	CcSEcCtD
Clomipramine—Sinusitis—Doxorubicin—uterine cancer	9.03e-05	0.00034	CcSEcCtD
Clomipramine—Visual impairment—Epirubicin—uterine cancer	9e-05	0.000339	CcSEcCtD
Clomipramine—Agranulocytosis—Doxorubicin—uterine cancer	8.98e-05	0.000338	CcSEcCtD
Clomipramine—Bradycardia—Doxorubicin—uterine cancer	8.79e-05	0.000331	CcSEcCtD
Clomipramine—Eye disorder—Epirubicin—uterine cancer	8.72e-05	0.000328	CcSEcCtD
Clomipramine—Hypersensitivity—Etoposide—uterine cancer	8.72e-05	0.000328	CcSEcCtD
Clomipramine—Tinnitus—Epirubicin—uterine cancer	8.7e-05	0.000328	CcSEcCtD
Clomipramine—Flushing—Epirubicin—uterine cancer	8.66e-05	0.000326	CcSEcCtD
Clomipramine—Cardiac disorder—Epirubicin—uterine cancer	8.66e-05	0.000326	CcSEcCtD
Clomipramine—Rhinitis—Doxorubicin—uterine cancer	8.66e-05	0.000326	CcSEcCtD
Clomipramine—Hepatitis—Doxorubicin—uterine cancer	8.64e-05	0.000325	CcSEcCtD
Clomipramine—Hypoaesthesia—Doxorubicin—uterine cancer	8.59e-05	0.000323	CcSEcCtD
Clomipramine—Pharyngitis—Doxorubicin—uterine cancer	8.57e-05	0.000323	CcSEcCtD
Clomipramine—Urinary tract disorder—Doxorubicin—uterine cancer	8.53e-05	0.000321	CcSEcCtD
Clomipramine—Asthenia—Etoposide—uterine cancer	8.49e-05	0.000319	CcSEcCtD
Clomipramine—Connective tissue disorder—Doxorubicin—uterine cancer	8.49e-05	0.000319	CcSEcCtD
Clomipramine—Angiopathy—Epirubicin—uterine cancer	8.47e-05	0.000319	CcSEcCtD
Clomipramine—Urethral disorder—Doxorubicin—uterine cancer	8.47e-05	0.000319	CcSEcCtD
Clomipramine—Immune system disorder—Epirubicin—uterine cancer	8.43e-05	0.000317	CcSEcCtD
Clomipramine—Mediastinal disorder—Epirubicin—uterine cancer	8.41e-05	0.000317	CcSEcCtD
Clomipramine—Chills—Epirubicin—uterine cancer	8.38e-05	0.000315	CcSEcCtD
Clomipramine—Pruritus—Etoposide—uterine cancer	8.37e-05	0.000315	CcSEcCtD
Clomipramine—Arrhythmia—Epirubicin—uterine cancer	8.34e-05	0.000314	CcSEcCtD
Clomipramine—Visual impairment—Doxorubicin—uterine cancer	8.32e-05	0.000313	CcSEcCtD
Clomipramine—Alopecia—Epirubicin—uterine cancer	8.25e-05	0.00031	CcSEcCtD
Clomipramine—Mental disorder—Epirubicin—uterine cancer	8.18e-05	0.000308	CcSEcCtD
Clomipramine—Malnutrition—Epirubicin—uterine cancer	8.13e-05	0.000306	CcSEcCtD
Clomipramine—Diarrhoea—Etoposide—uterine cancer	8.1e-05	0.000305	CcSEcCtD
Clomipramine—Eye disorder—Doxorubicin—uterine cancer	8.07e-05	0.000304	CcSEcCtD
Clomipramine—Tinnitus—Doxorubicin—uterine cancer	8.05e-05	0.000303	CcSEcCtD
Clomipramine—Flushing—Doxorubicin—uterine cancer	8.02e-05	0.000302	CcSEcCtD
Clomipramine—Cardiac disorder—Doxorubicin—uterine cancer	8.02e-05	0.000302	CcSEcCtD
Clomipramine—Flatulence—Epirubicin—uterine cancer	8.01e-05	0.000301	CcSEcCtD
Clomipramine—Tension—Epirubicin—uterine cancer	7.97e-05	0.0003	CcSEcCtD
Clomipramine—Dysgeusia—Epirubicin—uterine cancer	7.96e-05	0.000299	CcSEcCtD
Clomipramine—Nervousness—Epirubicin—uterine cancer	7.89e-05	0.000297	CcSEcCtD
Clomipramine—Back pain—Epirubicin—uterine cancer	7.86e-05	0.000296	CcSEcCtD
Clomipramine—Angiopathy—Doxorubicin—uterine cancer	7.84e-05	0.000295	CcSEcCtD
Clomipramine—Dizziness—Etoposide—uterine cancer	7.82e-05	0.000294	CcSEcCtD
Clomipramine—Muscle spasms—Epirubicin—uterine cancer	7.81e-05	0.000294	CcSEcCtD
Clomipramine—Immune system disorder—Doxorubicin—uterine cancer	7.8e-05	0.000294	CcSEcCtD
Clomipramine—Mediastinal disorder—Doxorubicin—uterine cancer	7.78e-05	0.000293	CcSEcCtD
Clomipramine—Chills—Doxorubicin—uterine cancer	7.75e-05	0.000292	CcSEcCtD
Clomipramine—Arrhythmia—Doxorubicin—uterine cancer	7.72e-05	0.00029	CcSEcCtD
Clomipramine—Vision blurred—Epirubicin—uterine cancer	7.66e-05	0.000288	CcSEcCtD
Clomipramine—Alopecia—Doxorubicin—uterine cancer	7.63e-05	0.000287	CcSEcCtD
Clomipramine—Mental disorder—Doxorubicin—uterine cancer	7.57e-05	0.000285	CcSEcCtD
Clomipramine—Ill-defined disorder—Epirubicin—uterine cancer	7.54e-05	0.000284	CcSEcCtD
Clomipramine—Vomiting—Etoposide—uterine cancer	7.52e-05	0.000283	CcSEcCtD
Clomipramine—Malnutrition—Doxorubicin—uterine cancer	7.52e-05	0.000283	CcSEcCtD
Clomipramine—Anaemia—Epirubicin—uterine cancer	7.51e-05	0.000283	CcSEcCtD
Clomipramine—Agitation—Epirubicin—uterine cancer	7.47e-05	0.000281	CcSEcCtD
Clomipramine—Rash—Etoposide—uterine cancer	7.46e-05	0.000281	CcSEcCtD
Clomipramine—Dermatitis—Etoposide—uterine cancer	7.45e-05	0.00028	CcSEcCtD
Clomipramine—Headache—Etoposide—uterine cancer	7.41e-05	0.000279	CcSEcCtD
Clomipramine—Flatulence—Doxorubicin—uterine cancer	7.41e-05	0.000279	CcSEcCtD
Clomipramine—Tension—Doxorubicin—uterine cancer	7.38e-05	0.000278	CcSEcCtD
Clomipramine—Dysgeusia—Doxorubicin—uterine cancer	7.36e-05	0.000277	CcSEcCtD
Clomipramine—Malaise—Epirubicin—uterine cancer	7.33e-05	0.000276	CcSEcCtD
Clomipramine—Nervousness—Doxorubicin—uterine cancer	7.3e-05	0.000275	CcSEcCtD
Clomipramine—Vertigo—Epirubicin—uterine cancer	7.3e-05	0.000275	CcSEcCtD
Clomipramine—Syncope—Epirubicin—uterine cancer	7.29e-05	0.000274	CcSEcCtD
Clomipramine—Leukopenia—Epirubicin—uterine cancer	7.27e-05	0.000274	CcSEcCtD
Clomipramine—Back pain—Doxorubicin—uterine cancer	7.27e-05	0.000274	CcSEcCtD
Clomipramine—Muscle spasms—Doxorubicin—uterine cancer	7.23e-05	0.000272	CcSEcCtD
Clomipramine—Palpitations—Epirubicin—uterine cancer	7.18e-05	0.00027	CcSEcCtD
Clomipramine—Loss of consciousness—Epirubicin—uterine cancer	7.14e-05	0.000269	CcSEcCtD
Clomipramine—Cough—Epirubicin—uterine cancer	7.09e-05	0.000267	CcSEcCtD
Clomipramine—Vision blurred—Doxorubicin—uterine cancer	7.09e-05	0.000267	CcSEcCtD
Clomipramine—Convulsion—Epirubicin—uterine cancer	7.04e-05	0.000265	CcSEcCtD
Clomipramine—Nausea—Etoposide—uterine cancer	7.03e-05	0.000264	CcSEcCtD
Clomipramine—Hypertension—Epirubicin—uterine cancer	7.02e-05	0.000264	CcSEcCtD
Clomipramine—Ill-defined disorder—Doxorubicin—uterine cancer	6.98e-05	0.000263	CcSEcCtD
Clomipramine—Anaemia—Doxorubicin—uterine cancer	6.95e-05	0.000262	CcSEcCtD
Clomipramine—Chest pain—Epirubicin—uterine cancer	6.92e-05	0.00026	CcSEcCtD
Clomipramine—Myalgia—Epirubicin—uterine cancer	6.92e-05	0.00026	CcSEcCtD
Clomipramine—Arthralgia—Epirubicin—uterine cancer	6.92e-05	0.00026	CcSEcCtD
Clomipramine—Agitation—Doxorubicin—uterine cancer	6.91e-05	0.00026	CcSEcCtD
Clomipramine—Anxiety—Epirubicin—uterine cancer	6.89e-05	0.000259	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	6.87e-05	0.000259	CcSEcCtD
Clomipramine—Discomfort—Epirubicin—uterine cancer	6.84e-05	0.000257	CcSEcCtD
Clomipramine—Malaise—Doxorubicin—uterine cancer	6.78e-05	0.000255	CcSEcCtD
Clomipramine—Dry mouth—Epirubicin—uterine cancer	6.77e-05	0.000255	CcSEcCtD
Clomipramine—Vertigo—Doxorubicin—uterine cancer	6.76e-05	0.000254	CcSEcCtD
Clomipramine—Syncope—Doxorubicin—uterine cancer	6.74e-05	0.000254	CcSEcCtD
Clomipramine—Leukopenia—Doxorubicin—uterine cancer	6.73e-05	0.000253	CcSEcCtD
Clomipramine—Confusional state—Epirubicin—uterine cancer	6.69e-05	0.000252	CcSEcCtD
Clomipramine—Palpitations—Doxorubicin—uterine cancer	6.64e-05	0.00025	CcSEcCtD
Clomipramine—Oedema—Epirubicin—uterine cancer	6.63e-05	0.00025	CcSEcCtD
Clomipramine—Anaphylactic shock—Epirubicin—uterine cancer	6.63e-05	0.00025	CcSEcCtD
Clomipramine—Loss of consciousness—Doxorubicin—uterine cancer	6.61e-05	0.000249	CcSEcCtD
Clomipramine—Cough—Doxorubicin—uterine cancer	6.56e-05	0.000247	CcSEcCtD
Clomipramine—Shock—Epirubicin—uterine cancer	6.52e-05	0.000246	CcSEcCtD
Clomipramine—Convulsion—Doxorubicin—uterine cancer	6.51e-05	0.000245	CcSEcCtD
Clomipramine—Nervous system disorder—Epirubicin—uterine cancer	6.5e-05	0.000245	CcSEcCtD
Clomipramine—Thrombocytopenia—Epirubicin—uterine cancer	6.49e-05	0.000244	CcSEcCtD
Clomipramine—Hypertension—Doxorubicin—uterine cancer	6.49e-05	0.000244	CcSEcCtD
Clomipramine—Tachycardia—Epirubicin—uterine cancer	6.47e-05	0.000244	CcSEcCtD
Clomipramine—Skin disorder—Epirubicin—uterine cancer	6.44e-05	0.000242	CcSEcCtD
Clomipramine—Hyperhidrosis—Epirubicin—uterine cancer	6.41e-05	0.000241	CcSEcCtD
Clomipramine—Myalgia—Doxorubicin—uterine cancer	6.4e-05	0.000241	CcSEcCtD
Clomipramine—Chest pain—Doxorubicin—uterine cancer	6.4e-05	0.000241	CcSEcCtD
Clomipramine—Arthralgia—Doxorubicin—uterine cancer	6.4e-05	0.000241	CcSEcCtD
Clomipramine—Anxiety—Doxorubicin—uterine cancer	6.38e-05	0.00024	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.36e-05	0.000239	CcSEcCtD
Clomipramine—Discomfort—Doxorubicin—uterine cancer	6.32e-05	0.000238	CcSEcCtD
Clomipramine—Anorexia—Epirubicin—uterine cancer	6.32e-05	0.000238	CcSEcCtD
Clomipramine—Dry mouth—Doxorubicin—uterine cancer	6.26e-05	0.000236	CcSEcCtD
Clomipramine—Hypotension—Epirubicin—uterine cancer	6.2e-05	0.000233	CcSEcCtD
Clomipramine—Confusional state—Doxorubicin—uterine cancer	6.19e-05	0.000233	CcSEcCtD
Clomipramine—Oedema—Doxorubicin—uterine cancer	6.14e-05	0.000231	CcSEcCtD
Clomipramine—Anaphylactic shock—Doxorubicin—uterine cancer	6.14e-05	0.000231	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.04e-05	0.000227	CcSEcCtD
Clomipramine—Shock—Doxorubicin—uterine cancer	6.04e-05	0.000227	CcSEcCtD
Clomipramine—Nervous system disorder—Doxorubicin—uterine cancer	6.02e-05	0.000226	CcSEcCtD
Clomipramine—Thrombocytopenia—Doxorubicin—uterine cancer	6.01e-05	0.000226	CcSEcCtD
Clomipramine—Insomnia—Epirubicin—uterine cancer	6e-05	0.000226	CcSEcCtD
Clomipramine—Tachycardia—Doxorubicin—uterine cancer	5.99e-05	0.000225	CcSEcCtD
Clomipramine—Skin disorder—Doxorubicin—uterine cancer	5.96e-05	0.000224	CcSEcCtD
Clomipramine—Paraesthesia—Epirubicin—uterine cancer	5.96e-05	0.000224	CcSEcCtD
Clomipramine—Hyperhidrosis—Doxorubicin—uterine cancer	5.93e-05	0.000223	CcSEcCtD
Clomipramine—Dyspnoea—Epirubicin—uterine cancer	5.91e-05	0.000223	CcSEcCtD
Clomipramine—Somnolence—Epirubicin—uterine cancer	5.9e-05	0.000222	CcSEcCtD
Clomipramine—Anorexia—Doxorubicin—uterine cancer	5.85e-05	0.00022	CcSEcCtD
Clomipramine—Dyspepsia—Epirubicin—uterine cancer	5.84e-05	0.00022	CcSEcCtD
Clomipramine—Decreased appetite—Epirubicin—uterine cancer	5.77e-05	0.000217	CcSEcCtD
Clomipramine—Hypotension—Doxorubicin—uterine cancer	5.73e-05	0.000216	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Epirubicin—uterine cancer	5.73e-05	0.000215	CcSEcCtD
Clomipramine—Fatigue—Epirubicin—uterine cancer	5.72e-05	0.000215	CcSEcCtD
Clomipramine—Constipation—Epirubicin—uterine cancer	5.67e-05	0.000213	CcSEcCtD
Clomipramine—Pain—Epirubicin—uterine cancer	5.67e-05	0.000213	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.59e-05	0.00021	CcSEcCtD
Clomipramine—Insomnia—Doxorubicin—uterine cancer	5.55e-05	0.000209	CcSEcCtD
Clomipramine—Paraesthesia—Doxorubicin—uterine cancer	5.51e-05	0.000207	CcSEcCtD
Clomipramine—Dyspnoea—Doxorubicin—uterine cancer	5.47e-05	0.000206	CcSEcCtD
Clomipramine—Feeling abnormal—Epirubicin—uterine cancer	5.47e-05	0.000206	CcSEcCtD
Clomipramine—Somnolence—Doxorubicin—uterine cancer	5.46e-05	0.000205	CcSEcCtD
Clomipramine—Gastrointestinal pain—Epirubicin—uterine cancer	5.42e-05	0.000204	CcSEcCtD
Clomipramine—Dyspepsia—Doxorubicin—uterine cancer	5.4e-05	0.000203	CcSEcCtD
Clomipramine—Decreased appetite—Doxorubicin—uterine cancer	5.33e-05	0.000201	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.3e-05	0.000199	CcSEcCtD
Clomipramine—Fatigue—Doxorubicin—uterine cancer	5.29e-05	0.000199	CcSEcCtD
Clomipramine—Urticaria—Epirubicin—uterine cancer	5.27e-05	0.000198	CcSEcCtD
Clomipramine—Constipation—Doxorubicin—uterine cancer	5.25e-05	0.000197	CcSEcCtD
Clomipramine—Pain—Doxorubicin—uterine cancer	5.25e-05	0.000197	CcSEcCtD
Clomipramine—Abdominal pain—Epirubicin—uterine cancer	5.24e-05	0.000197	CcSEcCtD
Clomipramine—Body temperature increased—Epirubicin—uterine cancer	5.24e-05	0.000197	CcSEcCtD
Clomipramine—Feeling abnormal—Doxorubicin—uterine cancer	5.06e-05	0.00019	CcSEcCtD
Clomipramine—Gastrointestinal pain—Doxorubicin—uterine cancer	5.02e-05	0.000189	CcSEcCtD
Clomipramine—Hypersensitivity—Epirubicin—uterine cancer	4.89e-05	0.000184	CcSEcCtD
Clomipramine—Urticaria—Doxorubicin—uterine cancer	4.87e-05	0.000183	CcSEcCtD
Clomipramine—Abdominal pain—Doxorubicin—uterine cancer	4.85e-05	0.000183	CcSEcCtD
Clomipramine—Body temperature increased—Doxorubicin—uterine cancer	4.85e-05	0.000183	CcSEcCtD
Clomipramine—Asthenia—Epirubicin—uterine cancer	4.76e-05	0.000179	CcSEcCtD
Clomipramine—Pruritus—Epirubicin—uterine cancer	4.69e-05	0.000177	CcSEcCtD
Clomipramine—Diarrhoea—Epirubicin—uterine cancer	4.54e-05	0.000171	CcSEcCtD
Clomipramine—Hypersensitivity—Doxorubicin—uterine cancer	4.52e-05	0.00017	CcSEcCtD
Clomipramine—Asthenia—Doxorubicin—uterine cancer	4.4e-05	0.000166	CcSEcCtD
Clomipramine—Dizziness—Epirubicin—uterine cancer	4.39e-05	0.000165	CcSEcCtD
Clomipramine—Pruritus—Doxorubicin—uterine cancer	4.34e-05	0.000163	CcSEcCtD
Clomipramine—Vomiting—Epirubicin—uterine cancer	4.22e-05	0.000159	CcSEcCtD
Clomipramine—Diarrhoea—Doxorubicin—uterine cancer	4.2e-05	0.000158	CcSEcCtD
Clomipramine—Rash—Epirubicin—uterine cancer	4.18e-05	0.000157	CcSEcCtD
Clomipramine—Dermatitis—Epirubicin—uterine cancer	4.18e-05	0.000157	CcSEcCtD
Clomipramine—Headache—Epirubicin—uterine cancer	4.15e-05	0.000156	CcSEcCtD
Clomipramine—Dizziness—Doxorubicin—uterine cancer	4.06e-05	0.000153	CcSEcCtD
Clomipramine—Nausea—Epirubicin—uterine cancer	3.94e-05	0.000148	CcSEcCtD
Clomipramine—Vomiting—Doxorubicin—uterine cancer	3.9e-05	0.000147	CcSEcCtD
Clomipramine—Rash—Doxorubicin—uterine cancer	3.87e-05	0.000146	CcSEcCtD
Clomipramine—Dermatitis—Doxorubicin—uterine cancer	3.87e-05	0.000145	CcSEcCtD
Clomipramine—Headache—Doxorubicin—uterine cancer	3.84e-05	0.000145	CcSEcCtD
Clomipramine—Nausea—Doxorubicin—uterine cancer	3.64e-05	0.000137	CcSEcCtD
Clomipramine—CYP1A2—Metabolism—POLD1—uterine cancer	5.27e-06	0.000422	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—EP300—uterine cancer	5.26e-06	0.000421	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—RRM2—uterine cancer	5.18e-06	0.000415	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—STAR—uterine cancer	5.18e-06	0.000415	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKR1B1—uterine cancer	5.18e-06	0.000415	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP11A1—uterine cancer	5.15e-06	0.000413	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ESR1—uterine cancer	5.14e-06	0.000411	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FBXW7—uterine cancer	5.12e-06	0.00041	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CDKN2B—uterine cancer	5.08e-06	0.000407	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—DCN—uterine cancer	5.03e-06	0.000403	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP11A1—uterine cancer	5.03e-06	0.000403	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—PIK3CA—uterine cancer	5.01e-06	0.000401	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—VEGFA—uterine cancer	4.98e-06	0.000399	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IGF1R—uterine cancer	4.93e-06	0.000395	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKR1C1—uterine cancer	4.93e-06	0.000394	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—NRAS—uterine cancer	4.92e-06	0.000394	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—STK11—uterine cancer	4.92e-06	0.000394	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—ERBB2—uterine cancer	4.92e-06	0.000394	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—CXCL8—uterine cancer	4.91e-06	0.000393	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CCL2—uterine cancer	4.9e-06	0.000392	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	4.87e-06	0.00039	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKR1C3—uterine cancer	4.87e-06	0.00039	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—NRAS—uterine cancer	4.86e-06	0.000389	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.79e-06	0.000384	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKR1C3—uterine cancer	4.75e-06	0.00038	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP11A1—uterine cancer	4.74e-06	0.00038	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PIK3CA—uterine cancer	4.74e-06	0.000379	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ESR1—uterine cancer	4.69e-06	0.000375	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CXCL8—uterine cancer	4.66e-06	0.000373	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SMAD3—uterine cancer	4.64e-06	0.000371	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—HRAS—uterine cancer	4.63e-06	0.000371	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SOCS3—uterine cancer	4.61e-06	0.000369	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CDKN1B—uterine cancer	4.55e-06	0.000365	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCL2—uterine cancer	4.52e-06	0.000362	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—AKT1—uterine cancer	4.5e-06	0.000361	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKR1C3—uterine cancer	4.48e-06	0.000358	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—STK11—uterine cancer	4.48e-06	0.000358	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CXCL8—uterine cancer	4.46e-06	0.000357	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CCL2—uterine cancer	4.45e-06	0.000357	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—NRAS—uterine cancer	4.43e-06	0.000355	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FGFR2—uterine cancer	4.42e-06	0.000354	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDKN2B—uterine cancer	4.41e-06	0.000353	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—RRM2—uterine cancer	4.39e-06	0.000352	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CTNNB1—uterine cancer	4.3e-06	0.000344	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1R—uterine cancer	4.28e-06	0.000343	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—CXCL8—uterine cancer	4.26e-06	0.000341	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—DCN—uterine cancer	4.26e-06	0.000341	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—KRAS—uterine cancer	4.24e-06	0.000339	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—PIK3CA—uterine cancer	4.23e-06	0.000339	CbGpPWpGaD
Clomipramine—ALB—Metabolism—STK11—uterine cancer	4.22e-06	0.000338	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP19A1—uterine cancer	4.22e-06	0.000338	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PTEN—uterine cancer	4.19e-06	0.000336	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SOCS3—uterine cancer	4.19e-06	0.000336	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—KRAS—uterine cancer	4.18e-06	0.000335	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—EP300—uterine cancer	4.15e-06	0.000333	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCL2—uterine cancer	4.13e-06	0.000331	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AKT1—uterine cancer	4.09e-06	0.000327	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—POLD1—uterine cancer	4.06e-06	0.000325	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SMAD3—uterine cancer	4.03e-06	0.000322	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—MTHFR—uterine cancer	4.02e-06	0.000322	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP11A1—uterine cancer	4.02e-06	0.000322	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDKN2B—uterine cancer	4.01e-06	0.000321	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—EP300—uterine cancer	4e-06	0.00032	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.96e-06	0.000317	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VEGFA—uterine cancer	3.93e-06	0.000315	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1R—uterine cancer	3.9e-06	0.000312	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—PIK3CA—uterine cancer	3.89e-06	0.000312	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—NRAS—uterine cancer	3.89e-06	0.000311	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CXCL8—uterine cancer	3.88e-06	0.000311	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—AKT1—uterine cancer	3.87e-06	0.00031	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CXCL8—uterine cancer	3.87e-06	0.00031	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—PIK3CA—uterine cancer	3.86e-06	0.000309	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—PIK3CA—uterine cancer	3.84e-06	0.000307	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGFR2—uterine cancer	3.84e-06	0.000307	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—KRAS—uterine cancer	3.82e-06	0.000305	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.8e-06	0.000304	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKR1C3—uterine cancer	3.79e-06	0.000304	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—STK11—uterine cancer	3.79e-06	0.000304	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP19A1—uterine cancer	3.79e-06	0.000304	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VEGFA—uterine cancer	3.79e-06	0.000303	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ESR1—uterine cancer	3.78e-06	0.000303	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.78e-06	0.000303	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ERBB2—uterine cancer	3.77e-06	0.000302	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—uterine cancer	3.77e-06	0.000302	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NRAS—uterine cancer	3.74e-06	0.000299	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP19A1—uterine cancer	3.7e-06	0.000296	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—STK11—uterine cancer	3.7e-06	0.000296	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SMAD3—uterine cancer	3.66e-06	0.000293	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—HRAS—uterine cancer	3.6e-06	0.000288	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—NRAS—uterine cancer	3.58e-06	0.000286	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CXCL8—uterine cancer	3.58e-06	0.000286	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.56e-06	0.000285	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HRAS—uterine cancer	3.55e-06	0.000284	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CXCL8—uterine cancer	3.52e-06	0.000282	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—PIK3CA—uterine cancer	3.51e-06	0.000281	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGFR2—uterine cancer	3.49e-06	0.00028	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CDKN1B—uterine cancer	3.49e-06	0.00028	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—STK11—uterine cancer	3.49e-06	0.000279	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP19A1—uterine cancer	3.49e-06	0.000279	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AKT1—uterine cancer	3.45e-06	0.000277	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ERBB2—uterine cancer	3.44e-06	0.000276	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.39e-06	0.000272	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—RRM2—uterine cancer	3.39e-06	0.000271	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—KRAS—uterine cancer	3.34e-06	0.000268	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCL2—uterine cancer	3.33e-06	0.000267	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CTNNB1—uterine cancer	3.3e-06	0.000264	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—DCN—uterine cancer	3.29e-06	0.000263	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ESR1—uterine cancer	3.29e-06	0.000263	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CXCL8—uterine cancer	3.26e-06	0.000261	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HRAS—uterine cancer	3.24e-06	0.00026	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—KRAS—uterine cancer	3.22e-06	0.000258	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PTEN—uterine cancer	3.22e-06	0.000257	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CDKN1B—uterine cancer	3.19e-06	0.000255	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—AKT1—uterine cancer	3.18e-06	0.000255	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MTHFR—uterine cancer	3.17e-06	0.000254	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AKT1—uterine cancer	3.15e-06	0.000252	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AKT1—uterine cancer	3.14e-06	0.000251	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—PIK3CA—uterine cancer	3.11e-06	0.000249	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—NRAS—uterine cancer	3.11e-06	0.000249	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.1e-06	0.000248	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—KRAS—uterine cancer	3.08e-06	0.000246	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—PIK3CA—uterine cancer	3.07e-06	0.000246	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EP300—uterine cancer	3.07e-06	0.000246	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CTNNB1—uterine cancer	3.01e-06	0.000241	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ESR1—uterine cancer	2.99e-06	0.000239	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—uterine cancer	2.97e-06	0.000238	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PIK3CA—uterine cancer	2.96e-06	0.000237	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—STK11—uterine cancer	2.95e-06	0.000237	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP19A1—uterine cancer	2.95e-06	0.000237	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PTEN—uterine cancer	2.94e-06	0.000235	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.93e-06	0.000234	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—uterine cancer	2.9e-06	0.000233	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL2—uterine cancer	2.89e-06	0.000232	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NRAS—uterine cancer	2.87e-06	0.00023	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AKT1—uterine cancer	2.86e-06	0.000229	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—uterine cancer	2.86e-06	0.000229	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MTHFR—uterine cancer	2.85e-06	0.000228	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—HRAS—uterine cancer	2.84e-06	0.000228	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PIK3CA—uterine cancer	2.83e-06	0.000226	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—NRAS—uterine cancer	2.83e-06	0.000226	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EP300—uterine cancer	2.8e-06	0.000224	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.8e-06	0.000224	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MTHFR—uterine cancer	2.78e-06	0.000223	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ERBB2—uterine cancer	2.78e-06	0.000222	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.77e-06	0.000222	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRAS—uterine cancer	2.74e-06	0.000219	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—PIK3CA—uterine cancer	2.7e-06	0.000217	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—KRAS—uterine cancer	2.67e-06	0.000214	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—uterine cancer	2.65e-06	0.000212	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.64e-06	0.000212	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCL8—uterine cancer	2.63e-06	0.000211	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL2—uterine cancer	2.63e-06	0.000211	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MTHFR—uterine cancer	2.62e-06	0.00021	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NRAS—uterine cancer	2.62e-06	0.00021	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRAS—uterine cancer	2.62e-06	0.000209	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CDKN1B—uterine cancer	2.57e-06	0.000206	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	2.54e-06	0.000204	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.51e-06	0.000201	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—AKT1—uterine cancer	2.51e-06	0.000201	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KRAS—uterine cancer	2.47e-06	0.000198	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	2.46e-06	0.000197	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	2.46e-06	0.000197	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	2.43e-06	0.000195	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	2.43e-06	0.000195	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKT1—uterine cancer	2.42e-06	0.000193	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ERBB2—uterine cancer	2.41e-06	0.000193	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTEN—uterine cancer	2.37e-06	0.00019	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AKT1—uterine cancer	2.31e-06	0.000185	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCL8—uterine cancer	2.29e-06	0.000183	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—STK11—uterine cancer	2.28e-06	0.000183	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.28e-06	0.000183	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRAS—uterine cancer	2.27e-06	0.000182	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PIK3CA—uterine cancer	2.27e-06	0.000182	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EP300—uterine cancer	2.26e-06	0.000181	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KRAS—uterine cancer	2.25e-06	0.00018	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTEN—uterine cancer	2.24e-06	0.000179	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	2.23e-06	0.000179	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	2.23e-06	0.000179	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MTHFR—uterine cancer	2.22e-06	0.000178	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	2.21e-06	0.000177	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—uterine cancer	2.19e-06	0.000176	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	2.19e-06	0.000176	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—uterine cancer	2.14e-06	0.000171	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—EP300—uterine cancer	2.13e-06	0.000171	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NRAS—uterine cancer	2.11e-06	0.000169	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	2.11e-06	0.000169	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRAS—uterine cancer	2.1e-06	0.000168	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	2.08e-06	0.000167	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PIK3CA—uterine cancer	2.07e-06	0.000166	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	2.07e-06	0.000165	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTEN—uterine cancer	2.06e-06	0.000165	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	2.03e-06	0.000163	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	2.01e-06	0.000161	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AKT1—uterine cancer	2.01e-06	0.000161	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—uterine cancer	2e-06	0.00016	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EP300—uterine cancer	1.96e-06	0.000157	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.96e-06	0.000157	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	1.92e-06	0.000154	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRAS—uterine cancer	1.92e-06	0.000153	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	1.87e-06	0.00015	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—uterine cancer	1.86e-06	0.000149	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKT1—uterine cancer	1.85e-06	0.000148	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NRAS—uterine cancer	1.83e-06	0.000147	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	1.83e-06	0.000146	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KRAS—uterine cancer	1.82e-06	0.000146	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EP300—uterine cancer	1.78e-06	0.000143	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTEN—uterine cancer	1.77e-06	0.000141	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MTHFR—uterine cancer	1.71e-06	0.000137	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKT1—uterine cancer	1.69e-06	0.000135	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	1.69e-06	0.000135	CbGpPWpGaD
Clomipramine—ALB—Metabolism—EP300—uterine cancer	1.68e-06	0.000135	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	1.67e-06	0.000134	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	1.67e-06	0.000134	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—uterine cancer	1.62e-06	0.000129	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTEN—uterine cancer	1.59e-06	0.000127	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KRAS—uterine cancer	1.58e-06	0.000126	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CA—uterine cancer	1.58e-06	0.000126	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTEN—uterine cancer	1.55e-06	0.000124	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRAS—uterine cancer	1.55e-06	0.000124	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—EP300—uterine cancer	1.51e-06	0.000121	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—EP300—uterine cancer	1.48e-06	0.000118	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTEN—uterine cancer	1.46e-06	0.000117	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	1.45e-06	0.000116	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	1.44e-06	0.000115	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—uterine cancer	1.4e-06	0.000112	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—EP300—uterine cancer	1.39e-06	0.000111	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKT1—uterine cancer	1.36e-06	0.000109	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRAS—uterine cancer	1.34e-06	0.000107	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	1.32e-06	0.000106	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AKT1—uterine cancer	1.29e-06	0.000103	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—uterine cancer	1.28e-06	0.000102	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CA—uterine cancer	1.25e-06	9.97e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTEN—uterine cancer	1.24e-06	9.89e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	1.22e-06	9.78e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT1—uterine cancer	1.19e-06	9.49e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—EP300—uterine cancer	1.18e-06	9.43e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.12e-06	8.95e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CA—uterine cancer	1.09e-06	8.74e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	1.08e-06	8.63e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.03e-06	8.23e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AKT1—uterine cancer	1.02e-06	8.15e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTEN—uterine cancer	9.53e-07	7.63e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKT1—uterine cancer	9.13e-07	7.31e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—EP300—uterine cancer	9.09e-07	7.28e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKT1—uterine cancer	8.92e-07	7.14e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CA—uterine cancer	8.71e-07	6.98e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKT1—uterine cancer	8.4e-07	6.73e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKT1—uterine cancer	7.12e-07	5.7e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CA—uterine cancer	6.72e-07	5.38e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKT1—uterine cancer	5.49e-07	4.4e-05	CbGpPWpGaD
